Mark A. Demitrack
Neuronetics
Inc.
Mark A. Demitrack has not added Biography.
If you are Mark A. Demitrack and would like to personalize this page please email our Author Liaison for assistance.
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
The Journal of clinical psychiatry Mar, 2002 | Pubmed ID: 11926722
The tyramine pressor test may have limited sensitivity, especially in the presence of dual serotonin/norepinephrine uptake inhibition.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology May, 2002 | Pubmed ID: 11927196
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
The Journal of clinical psychiatry Apr, 2002 | Pubmed ID: 12000204
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.
Journal of psychiatric research Nov-Dec, 2002 | Pubmed ID: 12393307
Effects of duloxetine on painful physical symptoms associated with depression.
Psychosomatics Jan-Feb, 2004 | Pubmed ID: 14709757
Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.
Brain, behavior, and immunity Jul, 2004 | Pubmed ID: 15157948
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
Journal of clinical psychopharmacology Aug, 2004 | Pubmed ID: 15232330
Can monoamine-based therapies be improved?
The Journal of clinical psychiatry , 2002 | Pubmed ID: 15453009
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Dec, 2004 | Pubmed ID: 15589385
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.
Pharmacogenomics Apr, 2006 | Pubmed ID: 16610962
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
Biological psychiatry Dec, 2007 | Pubmed ID: 17573044
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.
The Journal of clinical psychiatry Feb, 2008 | Pubmed ID: 18232722
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
The Journal of clinical psychiatry Mar, 2008 | Pubmed ID: 18294022
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Advances in therapy Mar, 2009 | Pubmed ID: 19330495
Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
Psychopharmacology bulletin , 2009 | Pubmed ID: 19629020
Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial".
Biological psychiatry Jan, 2010 | Pubmed ID: 19914602
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Brain stimulation Oct, 2010 | Pubmed ID: 20965447
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır